Does OBINUTUZUMAB Cause Hepatitis b? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Hepatitis b have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.2% of all adverse event reports for OBINUTUZUMAB.
29
Reports of Hepatitis b with OBINUTUZUMAB
0.2%
of all OBINUTUZUMAB reports
4
Deaths
8
Hospitalizations
How Dangerous Is Hepatitis b From OBINUTUZUMAB?
Of the 29 reports, 4 (13.8%) resulted in death, 8 (27.6%) required hospitalization, and 1 (3.4%) were considered life-threatening.
Is Hepatitis b Listed in the Official Label?
Yes, Hepatitis b is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Hepatitis b?
RITUXIMAB (597)
CYCLOPHOSPHAMIDE (578)
LAMIVUDINE (480)
DOXORUBICIN (469)
VINCRISTINE (431)
PREDNISOLONE (371)
TENOFOVIR DISOPROXIL (257)
PREDNISONE (208)
DEXAMETHASONE (173)
ENTECAVIR (166)
Which OBINUTUZUMAB Alternatives Have Lower Hepatitis b Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE